CRISPR Therapeutics AG

CRSP · NASDAQ

CRISPR Therapeutics AGCRSP · NASDAQ

Regular Market · Oct 30, 07:51 PM

$51.15-$3.11 -5.73%

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about CRSP

CRISPR Therapeutics AG

CRSP · Biotechnology

51.15 USD

-3.11 (-5.73%)

Regular Market

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

CRISPR Therapeutics AG

CRSP · NASDAQ

Regular Market

51.15 USD

-3.11 (-5.73%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

CRSP extended its drop in the broad technology-led risk-off selloff.

No new catalyst: CRSP was down about 6.7%, deeper than the roughly 3.9% decline earlier, as the S&P 500 and Nasdaq sold off sharply and volatility jumped. The MHRA's approval of CASGEVY for children age five and older remained positive company news, while Vertex and the healthcare benchmark rose.

reuters.com

Unusual Price Movement

CRSP extended its drop in the broad technology-led risk-off selloff.

Sources:

MHRA Approves Gene-Editing Treatment For Children Aged 5 & Over With Serious Inherited Blood Disorders

Ask Alva anything. @ for context, / for skills

Ask Alva about CRSP

CRSP extended its drop in the broad technology-led risk-off selloff. ⓘ

CRSP extended its drop in the broad technology-led risk-off selloff. ⓘ

CRSP extended its drop in the broad technology-led risk-off selloff.

CRSP extended its drop in the broad technology-led risk-off selloff.